페이지 정보Date21-08-23 15:46 Number of views681
PharmaResearch, Completes ‘REJURAN’ Launching Symposium in Xinjiang Province, China
Set the Stage for Academic Exchanges...Introduction of ‘Practical Story of REJURAN'
PharmaResearch Co., Ltd. (CEO Kim Shin-kyu, Kang Ki-Seock) announced on the 10th that REJURAN Launching Symposium was successfully held in Xinjiang, China.
PharmaResearch held a REJURAN Launching Symposium on the 4th in Urumqi City, Xinjiang Autonomous Region in collaboration with their Chinese partner company, Yxintent. The symposium was scaled back with only the key officials in attendance due to the coronavirus outbreak.
At the REJURAN Symposium, Dr. Kim Soo-Rim of TATOA China and PharmaResearch senior researcher Ok Seul-Ong each delivered in-depth lectures on REJURAN under the theme of ‘Practical Story of REJURAN’ and ‘The Regenerative Medical Device REJURAN.’
With this launch, REJURAN will enter the market in 17 regions in China, including Beijing, Shanghai, Zhejiang, Jiangsu and Sichuan provinces, as well as Xinjiang.
Since signing an exclusive distribution agreement with Yxintent in January of last year, PharmaResearch has established an all-out network in China through the REJURAN Launching Symposium, hands-on seminars and major academic conferences.
A PharmaResearch official revealed, “China is a very promising market for growth in the medical beauty sector” and continued, “We will continue our marketing activities to help REJURAN establish itself as a leading aesthetic product in the Chinese market.”
Meanwhile, PharmaResearch is a regenerative medicine-based biopharmaceutical company that manufactures and sells pharmaceuticals, medical devices, cosmetics, and health functional foods, focusing on tissue regeneration materials, DOT™ PDRN and DOT™ PN. The top line of the products are Rejuran®, Conjuran®, Rejuran®Cosmetic and Re-An® Eye drops.